0001564590-22-004229.txt : 20220208 0001564590-22-004229.hdr.sgml : 20220208 20220208160121 ACCESSION NUMBER: 0001564590-22-004229 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220204 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220208 DATE AS OF CHANGE: 20220208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562181648 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 22601535 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 8-K 1 scyx-8k_20220204.htm 8-K scyx-8k_20220204.htm
false 0001178253 0001178253 2022-02-04 2022-02-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 4, 2022

SCYNEXIS, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

Delaware

 

001-36365

 

56-2181648

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1 Evertrust Plaza, 13th Floor

Jersey City, New Jersey 07302-6548

(Address of Principal Executive Offices, and Zip Code)

(201)-884-5485

Registrant’s Telephone Number, Including Area Code

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001

 

SCYX

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 4, 2022, the Compensation Committee of the Board of Directors of SCYNEXIS, Inc. granted restricted stock units (“RSUs”) to a number of its employees and executive officers, including to Marco Taglietti, M.D., its President and Chief Executive Officer, and David Angulo, M.D., its Chief Medical Officer. The grants were made pursuant to the SCYNEXIS, Inc. 2014 Equity Incentive Plan and a Restricted Stock Unit Award Grant Notice and Award Agreement.  The form of Restricted Stock Unit Award Grant Notice and Award Agreement is attached hereto as Exhibit 10.1.  The grants to Dr. Taglietti and Dr. Angulo were as follows:

 

Executive Officer

Number of Shares

Vesting Schedule

 

 

 

Marco Taglietti, M.D.

87,200

(1)

 

 

 

David Angulo, M.D.

51,100

(1)

 

(1)

These RSUs will vest over two years, with 50% vesting each year on the anniversary of the date of grant.

 

In addition, each of these officers were granted an option to purchase shares of SCYNEXIS common stock (232,000 shares in the case of Dr. Taglietti and 85,000 shares in the case of Dr. Angulo) with an exercise price of $4.60, the closing price on the date of grant, which will vest in equal monthly installments over 48 months.

 

Item 9.01. Financial Statements and Exhibits.

Exhibit No.Description

 

10.1Form of Restricted Stock Unit Grant Notice and Award Agreement

104Cover Page Interactive Data File (formatted as Inline XBRL).


 

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

SCYNEXIS, Inc.

 

 

 

 

Date: February 8, 2022

 

 

 

By:

 

/s/ Marco Taglietti

 

 

 

 

Name:

 

Marco Taglietti, M.D.

 

 

 

 

Its:

 

Chief Executive Officer

 

 EX-10.1 2 scyx-ex101_7.htm EX-10.1 scyx-ex101_7.htm

 

Exhibit 10.1

2014 SCYNEXIS, Inc.

Restricted Stock Unit Award Grant Notice

2014 Equity Incentive plan

 

SCYNEXIS, Inc. (the “Company”) hereby awards to Participant the number of Restricted Stock Units specified and on the terms set forth below (the “Award”).  The Award is subject to all of the terms and conditions as set forth  in this Restricted Stock Unit Grant Notice (the “Grant Notice”), in the Restricted Stock Unit Award Agreement (the “Award Agreement”) and in the Company’s 2014 Equity Incentive Plan (the “Plan”), all of which are attached hereto and incorporated herein in their entirety.  Capitalized terms not explicitly defined herein but defined in the Plan or the Award Agreement shall have the meanings set forth in the Plan or the Award Agreement, as applicable.  In the event of any conflict between the terms of this Grant Notice, the Award Agreement or the Plan, the terms of the Plan shall control.

Participant:

Employee ID Number:

 

Date of Grant:

 

Vesting Commencement Date:

 

Number of Restricted Stock Units:

 

Settlement Date:

One share of Common Stock of the Company will be issued for each Restricted Stock Unit (subject to any Capitalization Adjustment) that vests at the time set forth in Section 6 of the Award Agreement.

Vesting Schedule:

 

 

 

Additional Terms/Acknowledgements:  Participant acknowledges receipt of, and understands and agrees to, this Restricted Stock Unit Grant Notice, the Restricted Stock Unit Agreement and the Plan.  Participant acknowledges and agrees that this Restricted Stock Unit Grant Notice and the Restricted Stock Unit Agreement may not be modified, amended or revised except as provided in the Plan.  Participant further acknowledges that as of the Date of Grant, this Restricted Stock Unit Grant Notice, the Restricted Stock Unit Agreement, and the Plan set forth the entire understanding between Participant and the Company regarding this award and supersede all prior oral and written agreements, promises and/or representations on that subject with the exception of (i) restricted stock units previously granted and delivered to Participant, (ii) any compensation recovery policy that is adopted by the Company or is otherwise required by applicable law and (iii) any written employment or severance arrangement that would provide for vesting acceleration of this award upon the terms and conditions set forth therein.  

 

By accepting the Award, Participant acknowledges having received and read the Restricted Stock Unit Grant Notice, the Restricted Stock Unit Award Agreement and the Plan (the “Grant Documents”) and agrees to all of the terms and conditions set forth in these documents.  Furthermore, by accepting this Award, Participant consents to receive such documents by electronic delivery and to participate in the Plan through an online or electronic system established and maintained by the Company or another third party designated by the Company.

 

Your electronic signature indicates your agreement to be bound by the terms of this Agreement.

 

The Participant hereby accepts the Award subject to all of the terms and conditions of this Notice, the Award Agreement and the Plan.  Participant consents to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

 

 

 

SCYNEXIS, INC.                                                                       PARTICIPANT

 

By:

Signature

Its:

Date

 

Address

 

 

 

Attachments: Award Agreement and 2014 Equity Incentive Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Scynexis, Inc.

2014 Equity Incentive Plan

Restricted Stock Unit Award Agreement

Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) and this Restricted Stock Unit Award Agreement (the “Award Agreement”) and in consideration of your services, SCYNEXIS, Inc. (the “Company”) has awarded you a Restricted Stock Unit Award (the “Award”) under its 2014 Equity Incentive Plan (the “Plan”) for the number of Restricted Stock Units indicated in the Grant Notice (the “Stock Units”).  Capitalized terms not explicitly defined in this Award Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.    

The details of your Award, in addition to those set forth in the Grant Notice and the Plan are as follows:

1.Grant of the Award.  This Award represents your right to be issued on a future date one share of the Company’s Common Stock for each Stock Unit indicated in the Grant Notice that vests.    As of the Date of Grant specified in the Grant Notice, the Company will credit to a bookkeeping account maintained by the Company for your benefit (the “Account”) the number of Stock Units subject to the Award.  This Award was granted in consideration of your services to the Company.

2.Vesting.  Subject to the provisions contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice.  Vesting will cease upon the termination of your Continuous Service for any reason.  Upon such termination of your Continuous Service, any Stock Units credited to the Account that were not yet vested on the date of such termination will be forfeited at no cost to the Company and you will have no further right, title or interest in such Stock Units or the shares of Common Stock to be issued in respect of such portion of the Award.

3.Number of Stock Units and Shares of Common Stock.

(a)The Stock Units subject to your Award will be adjusted for Capitalization Adjustments, as provided in the Plan.

(b)Any additional Stock Units and any shares, cash or other property that become subject to the Award pursuant to this Section 3, if any, will be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable to the other Stock Units and shares covered by your Award.

(c)No fractional shares or rights for fractional shares of Common Stock will be created pursuant to this Section 3.  Except as provided in Section 7 or otherwise provided by the Company, any fraction of a share will be rounded down to the nearest whole share.

 

 

4.Securities Law Compliance.  You will not be issued any Common Stock in respect of your Stock Units or other shares with respect to your Stock Units unless either (i) the shares are registered under the Securities Act, or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Your Award also must comply with all other applicable laws and regulations governing the Award, and you will not receive such shares if the Company determines that such receipt would not be in material compliance with such laws and regulations.

5.Transferability.  Prior to the time that shares of Common Stock have been delivered to you, you may not transfer, pledge, sell or otherwise dispose of any portion of the Stock Units or the shares in respect of your Stock Units.  For example, you may not use shares that may be issued in respect of your Stock Units as security for a loan, nor may you transfer, pledge, sell or otherwise dispose of such shares.  This restriction on transfer will lapse upon delivery to you of shares in respect of your vested Stock Units.  

(a)Death.  Your Stock Units are not transferable other than by will and by the laws of descent and distribution.  Upon receiving written permission from the Board or its duly authorized designee, you may, by delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company and any broker designated by the Company to effect transactions under the Plan, designate a third party who, in the event of your death, will thereafter be entitled to receive any distribution of Common Stock or other consideration to which you were entitled at the time of your death pursuant to this Award Agreement.  In the absence of such a designation, your executor or administrator of your estate will be entitled to receive, on behalf of your estate, such Common Stock or other consideration.  

(b)Domestic Relations Orders.  Upon receiving written permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your right to receive the distribution of Common Stock or other consideration under your Stock Units, pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by applicable law that contains the information required by the Company to effectuate the transfer.  You are encouraged to discuss with the Company the proposed terms of any such transfer prior to finalizing the domestic relations order or marital settlement agreement to help ensure the required information is contained within the domestic relations order, marital settlement agreement or other divorce or separation instrument.  The Company is not obligated to allow you to transfer your Award in connection with your domestic relations order, marital settlement agreement or other divorce or separation instrument.

6.Date of Issuance.  

(a)To the extent that your Award is exempt from the application of Section 409A of the Code, the issuance of shares in respect of the Stock Units is intended to comply with Treasury Regulation Section 1.409A-1(b)(4) and will be construed and administered in such a manner.

(b)Subject to the satisfaction of the withholding obligations set forth in Section 10 of this Award Agreement, in the event one or more Stock Units vests, the Company will issue

 

 

to you, on the vesting date, one share of Common Stock for each Stock Unit that vests and such issuance date is referred to as the “Original Issuance Date.” If the Original Issuance Date falls on a date that is not a business day, delivery will instead occur on the next following business day.

(c)However, if (i) the Original Issuance Date does not occur (1) during an “open window period” applicable to you, as determined by the Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date when you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including but not limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange Act and was entered into in compliance with the Company’s policies (a “10b5-1 Plan”)), and (ii) the Company elects, prior to the Original Issuance Date, not to satisfy the Withholding Taxes described in Section 10 by withholding shares of Common Stock from the shares otherwise due, on the Original Issuance Date, to you under this Award, then the shares that would otherwise be issued to you on the Original Issuance Date will not be delivered on such Original Issuance Date and will instead be delivered on the first business day when you are not prohibited from selling shares of the Company’s Common Stock in the open public market, but in no event later than December 31 of the calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or, if and only if permitted in a manner that complies with Treasury Regulation Section 1.409A-1(b)(4), no later than the date that is the later of (i) the 15th day of the third month following the end of the calendar year in which such shares of Common Stock under this Award are no longer subject to a “substantial risk of forfeiture” within the meaning of Treasury Regulation Section 1.409A-1(d) or (ii) the 15th day of the third month following the end of the Company’s fiscal year in which such shares of Common Stock under this Award are no longer subject to a “substantial risk of forfeiture” within the meaning of Treasury Regulation Section 1.409A-1(d).

7.Dividends. You will receive no benefit or adjustment to your Award or Stock Units with respect to any cash dividend, stock dividend or other distribution that does not constitute a Capitalization Adjustment as provided in the Plan; provided, however, that this sentence will not apply with respect to any shares of Common Stock that are delivered to you in connection with your Award after such shares have been delivered to you.

8.Restrictive Legends.  The Common Stock issued with respect to your Stock Units will be endorsed with appropriate legends, if any, as determined by the Company.

9.Award not a Service Contract.  

(a)Except as otherwise provided in a separate, written employment or other agreement between the Company and/or its Affiliates and you, your Continuous Service is not for any specified term and may be terminated by you or by the Company or an Affiliate at any time, for any reason, with or without cause and with or without notice.  Nothing in this Award Agreement (including, but not limited to, the vesting of your Stock Units or the issuance of the shares in respect of your Stock Units), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Award Agreement or the Plan will:  (i) confer upon you any right to continue in the employ or service of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of

 

 

employment or affiliation; (iii) confer any right or benefit under this Award Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Award Agreement or Plan; or (iv) deprive the Company of the right to terminate you at will and without regard to any future vesting opportunity that you may have.

(b)By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to the vesting schedule provided in the Grant Notice is earned only by continuing as an employee, director or consultant at the will of the Company or an Affiliate, as applicable (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time to time, as it deems appropriate (a “reorganization”).  You further acknowledge and agree that such a reorganization could result in the termination of your Continuous Service, or the termination of Affiliate status of your employer and the loss of benefits available to you under this Award Agreement, including but not limited to, the termination of the right to continue vesting in the Award.  You further acknowledge and agree that this Award Agreement, the Plan, the transactions contemplated hereunder and the vesting schedule set forth herein or any covenant of good faith and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement as an employee or consultant for the term of this Award Agreement, for any period, or at all, and shall not interfere in any way with your right or the Company’s right to terminate your Continuous Service at any time, with or without cause and with or without notice.

10.Withholding Obligations.

(a)On each vesting date, and on or before the time you receive a distribution of the shares in respect of your Stock Units, and at any other time as reasonably requested by the Company in accordance with applicable tax laws, you hereby authorize any required withholdings from the shares of Common Stock issuable to you and/or otherwise agree to make adequate provision, including in cash, for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or any Affiliate that arise in connection with your Award (the “Withholding Taxes”).  Specifically, the Company or an Affiliate may, in its sole discretion, satisfy all or any portion of the Withholding Taxes relating to your Award by any of the following means or by a combination of such means: (i) withholding from any compensation otherwise payable to you by the Company or an Affiliate; (ii) causing you to tender a cash payment; (iii) permitting or requiring you to enter into a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby you irrevocably elect to sell a portion of the shares to be delivered in connection with your Stock Units to satisfy the Withholding Taxes and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Withholding Taxes directly to the Company and/or its Affiliates; or (iv) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to you in connection with your Stock Units with a Fair Market Value (measured as of the date shares of Common Stock are issued to you) equal to the amount of such Withholding Taxes; provided, however, that the number of such shares of Common Stock so withheld will not exceed the amount necessary to satisfy the Company’s required tax withholding obligations using the minimum statutory withholding rates for federal, state, local and, if applicable, foreign tax purposes, including payroll taxes, that are applicable to supplemental taxable income; and provided further, that to the extent necessary to qualify for an

 

 

exemption from application of Section 16(b) of the Exchange Act, such share withholding procedure shall be subject to the express prior approval of the Board or a duly authorized committee thereof.  

(b)Unless the Withholding Taxes of the Company and/or any Affiliate are satisfied, the Company will have no obligation to deliver to you any Common Stock or other consideration pursuant to this Award.

(c)In the event the Company’s obligation to withhold arises prior to the delivery to you of Common Stock or it is determined after the delivery of Common Stock to you that the amount of the Company’s withholding obligation was greater than the amount withheld by the Company, you agree to indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount.

11.Unsecured Obligation.  Your Award is unfunded, and as a holder of vested Stock Units, you will be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares or other property pursuant to this Award Agreement.  You will not have voting or any other rights as a shareholder of the Company with respect to the shares to be issued pursuant to this Award Agreement until such shares are issued to you.   Upon such issuance, you will obtain full voting and other rights as a shareholder of the Company.  Nothing contained in this Award Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.

12.Other Documents.  You hereby acknowledge receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus.  In addition, you acknowledge receipt of the Company’s policy permitting certain individuals to sell shares only during certain “window” periods and the Company’s insider trading policy, in effect from time to time.  

13.Notices.  Any notices provided for in this Award Agreement or the Plan will be given in writing (including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.  The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means.  By accepting this Award, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

14.Personal Data.  You understand that your employer, if applicable, the Company, and/or its Affiliates hold certain personal information about you, including but not limited to your name, home address, telephone number, date of birth, social security or equivalent tax identification number, salary, nationality, job title, and details of your Award (the “Personal Data”).  Certain Personal Data may also constitute “Sensitive Personal Data” or similar classification under applicable local law and be subject to additional restrictions on collection, processing and use of the same under such laws.  Such data include but are not limited to Personal

 

 

Data and any changes thereto, and other appropriate personal and financial data about you.  You hereby provide express consent to the Company or its Affiliates to collect, hold, and process any such Personal Data and Sensitive Personal Data.  You also hereby provide express consent to the Company and/or its Affiliates to transfer any such Personal Data and Sensitive Personal Data outside the country in which you are employed or retained, including transfers to the United States, if applicable.  The legal persons for whom such Personal Data are intended are the Company and any broker company providing services to the Company in connection with the administration of the Plan.  You have been informed of your right to access and correct your Personal Data and/or Sensitive Personal Data by applying to the Company.

15.Additional Acknowledgements.  You hereby consent and acknowledge that:

(a)Participation in the Plan is voluntary and therefore you must accept the terms and conditions of the Plan and this Award Agreement and Grant Notice as a condition to participating in the Plan and receipt of this Award.  This Award and any other awards under the Plan are voluntary and occasional and do not create any contractual or other right to receive future awards or other benefits in lieu of future awards, even if similar awards have been granted repeatedly in the past. All determinations with respect to any such future awards, including, but not limited to, the time or times when such awards are made, the size of such awards and performance and other conditions applied to the awards, will be at the sole discretion of the Company.

(b)The future value of your Award is unknown and cannot be predicted with certainty.  You do not have, and will not assert, any claim or entitlement to compensation, indemnity or damages arising from the termination of this Award or diminution in value of this Award and you irrevocably release the Company, its Affiliates and, if applicable, your employer, if different from the Company, from any such claim that may arise.

(c)The rights and obligations of the Company under your Award will be transferable to any one or more persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by the Company’s successors and assigns.

(d)Upon request, you agree to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your Award.

(e)You  have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award, and fully understand all provisions of your Award.

(f)This Award Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

(g)All obligations of the Company under the Plan and this Award Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

 

 

16.Governing Plan Document.  Your Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan.  In addition, your Award will be subject to recoupment in accordance with any clawback policy that the Company has adopted or any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as is otherwise required by the Dodd–Frank Wall Street Reform and Consumer Protection Act or other applicable law. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for “good reason” or “constructive termination” (or similar term) under any plan of or agreement with the Company.  Except as expressly provided in this Award Agreement or the Grant Notice, in the event of any conflict between the provisions of your Award and those of the Plan, the provisions of the Plan will control.

17.Severability.  If all or any part of this Award Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Award Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Award Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.

18.Effect on Other Employee Benefit Plans.  The value of the Award subject to this Award Agreement will not be included as compensation, earnings, salaries, or other similar terms used when calculating the Employee’s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit plans.

19.Amendment.  Any amendment to this Award Agreement must be in writing, signed by a duly authorized representative of the Company. The Board reserves the right to amend this Award Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a result of any change in applicable laws or regulations or any future law, regulation, interpretation,  ruling, or judicial decision.

20.Compliance with Section 409A of the Code.  This Award is intended to be exempt from the application of Section 409A of the Code, including but not limited to by reason of complying with the “short-term deferral” rule set forth in Treasury Regulation Section 1.409A-1(b)(4) and any ambiguities herein shall be interpreted accordingly.  However, if this Award fails to satisfy the requirements of the short-term deferral rule and is otherwise not exempt from, and therefore deemed to be deferred compensation subject to, Section 409A of the Code, this Award shall comply with Section 409A of the Code to the extent necessary to avoid adverse personal tax consequences and any ambiguities herein shall be interpreted accordingly.  To the extent this Award is subject to Section 409A of the Code and if you are a “Specified Employee” (within the meaning set forth Section 409A(a)(2)(B)(i) of the Code) as of the date of your separation from service (within the meaning of Treasury Regulation Section 1.409A-1(h)), then the issuance of any shares that would otherwise be made upon the date of the separation from service or within the first six months thereafter will not be made on the originally scheduled dates and will instead be

 

 

issued in a lump sum on the date that is six months and one day after the date of the separation from service, with the balance of the shares issued thereafter in accordance with the original vesting and issuance schedule set forth above, but if and only if such delay in the issuance of the shares is necessary to avoid the imposition of taxation on you in respect of the shares under Section 409A of the Code.  Each installment of shares that vests is a “separate payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2).  

21.No Obligation to Minimize Taxes. The Company has no duty or obligation to minimize the tax consequences to you of this Award and will not be liable to you for any adverse tax consequences to you arising in connection with this Award.  You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the tax consequences of this Award and by signing the Grant Notice, you have agreed that you have done so or knowingly and voluntarily declined to do so.  

***

This Restricted Stock Unit Award Agreement will be deemed to be accepted by you upon your acceptance of the Restricted Stock Unit Grant Notice to which it is attached.

 

 

 

 EX-101.SCH 3 scyx-20220204.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 scyx-20220204_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Document - Document and Entity Information [Abstract] Document Document And Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 5 scyx-20220204_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information
Feb. 04, 2022
Document Document And Entity Information [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 04, 2022
Entity Registrant Name SCYNEXIS, Inc.
Entity Central Index Key 0001178253
Entity Emerging Growth Company false
Entity File Number 001-36365
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 56-2181648
Entity Address, Address Line One 1 Evertrust Plaza
Entity Address, Address Line Two 13th Floor
Entity Address, City or Town Jersey City
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07302-6548
City Area Code 201
Local Phone Number 884-5485
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol SCYX
Security Exchange Name NASDAQ
XML 7 scyx-8k_20220204_htm.xml IDEA: XBRL DOCUMENT 0001178253 2022-02-04 2022-02-04 false 0001178253 8-K 2022-02-04 SCYNEXIS, Inc. DE 001-36365 56-2181648 1 Evertrust Plaza 13th Floor Jersey City NJ 07302-6548 201 884-5485 false false false false Common Stock, par value $0.001 SCYX NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 122 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports scyx-8k_20220204.htm scyx-20220204.xsd scyx-20220204_lab.xml scyx-20220204_pre.xml scyx-ex101_7.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "scyx-8k_20220204.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "scyx-8k_20220204.htm" ] }, "labelLink": { "local": [ "scyx-20220204_lab.xml" ] }, "presentationLink": { "local": [ "scyx-20220204_pre.xml" ] }, "schema": { "local": [ "scyx-20220204.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "scyx", "nsuri": "http://www.scynexis.com/20220204", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "scyx-8k_20220204.htm", "contextRef": "C_0001178253_20220204_20220204", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "scyx-8k_20220204.htm", "contextRef": "C_0001178253_20220204_20220204", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "verboseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.scynexis.com/20220204/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "scyx_DocumentDocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document Document And Entity Information [Abstract]", "terseLabel": "Document - Document and Entity Information [Abstract]" } } }, "localname": "DocumentDocumentAndEntityInformationAbstract", "nsuri": "http://www.scynexis.com/20220204", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001564590-22-004229-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-004229-xbrl.zip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end